Literature DB >> 25115100

Seasonal variations in the composition of the essential oils of Lavandula angustifolia (Lamiacae).

Branislava Lakusić, Dmitar Lakusić, Mihailo Ristić, Mirjana Marcetić, Violeta Slavkovska.   

Abstract

Seasonal variations in the composition of the essential oils obtained from the same individual (of the same genotype) of Lavandula angustifolia cultivated in Belgrade were determined by GC and GC/MS. The main constituents were 1,8-cineole (7.1-48.4%), linalool (0.1-38.7%), bomeol (10.9-27.7%), beta-phellandrene (0.5-21.2%) and camphor (1.5-15.8%). Cluster analysis showed that the 21 samples collected each month during the vegetation cycle were separable into three main clades with different compositions of essential oils. In the shoots with flowers, inflorescences and fruits of clade I, linalool is dominant, in the young leaves before flowering and old leaves of clade II, 1,8-cineole is dominant. In the young and incompletely developed leaves of clade III, beta-phellandrene is dominant. The composition of the essential oils of lavender depended on the plant part and the stage of development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115100

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  2 in total

Review 1.  Essential Oils and Their Constituents: An Alternative Source for Novel Antidepressants.

Authors:  Damião P de Sousa; Rayanne H N Silva; Epifanio F da Silva; Elaine C Gavioli
Journal:  Molecules       Date:  2017-08-03       Impact factor: 4.411

2.  Effect of Lavender (Lavandula angustifolia) Essential Oil on Acute Inflammatory Response.

Authors:  Gabriel Fernando Esteves Cardia; Saulo Euclides Silva-Filho; Expedito Leite Silva; Nancy Sayuri Uchida; Heitor Augusto Otaviano Cavalcante; Larissa Laila Cassarotti; Valter Eduardo Cocco Salvadego; Ricardo Alexandre Spironello; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.